SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1q5r'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MX1_B_THAB2_1 (LIVER CARBOXYLESTERASE I)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	LEU H 14 GLY H 44 VAL H 87 LEU H 104 LEU H 83	None	1.24A	1mx1B-1q5rH: undetectable	1mx1B-1q5rH: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MX1_C_THAC3_1 (LIVER CARBOXYLESTERASE I)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	LEU H 14 GLY H 44 VAL H 87 LEU H 104 LEU H 83	None	1.21A	1mx1C-1q5rH: undetectable	1mx1C-1q5rH: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MX1_E_THAE5_1 (LIVER CARBOXYLESTERASE I)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	LEU H 14 GLY H 44 VAL H 87 LEU H 104 LEU H 83	None	1.19A	1mx1E-1q5rH: undetectable	1mx1E-1q5rH: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_H_BO2H1400_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	6 / 11	GLN H 22 ALA H 27 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.49A	2f16H-1q5rH: 23.8 2f16I-1q5rH: 20.5	2f16H-1q5rH: 27.16 2f16I-1q5rH: 24.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_K_BO2K1402_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	6 / 10	ALA H 20 THR H 21 ALA H 27 VAL H 31 GLY H 47 ALA H 49	None	0.47A	2f16K-1q5rH: 23.8 2f16L-1q5rH: 22.5	2f16K-1q5rH: 27.59 2f16L-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_V_BO2V1401_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	6 / 11	GLN H 22 ALA H 27 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.50A	2f16V-1q5rH: 23.8 2f16W-1q5rH: 23.4	2f16V-1q5rH: 27.16 2f16W-1q5rH: 24.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F16_Y_BO2Y1403_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	6 / 10	ALA H 20 THR H 21 ALA H 27 VAL H 31 GLY H 47 ALA H 49	None	0.47A	2f16Y-1q5rH: 13.4 2f16Z-1q5rH: 22.3	2f16Y-1q5rH: 27.59 2f16Z-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_G_ASDG1224_1 (GLUTATHIONE S-TRANSFERASE A3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 7	LEU H 14 ALA H 167 LEU H 171 ALA H 146	None	0.90A	2vcvG-1q5rH: undetectable	2vcvG-1q5rH: 25.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KEE_B_30BB500_1 (GENOME POLYPROTEIN)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	GLY H -1 VAL H 195 GLY H 16 ALA H 43 ALA H 42	None	1.11A	3keeB-1q5rH: undetectable	3keeB-1q5rH: 22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KEE_C_30BC500_1 (GENOME POLYPROTEIN)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	GLY H -1 VAL H 195 GLY H 16 ALA H 43 ALA H 42	None	1.06A	3keeC-1q5rH: undetectable	3keeC-1q5rH: 22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_H_BO2H1400_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 1 THR H 21 GLN H 22 GLY H 47 THR H 48	None	1.03A	3mg0H-1q5rH: 23.8 3mg0I-1q5rH: 20.4	3mg0H-1q5rH: 27.16 3mg0I-1q5rH: 24.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_H_BO2H1400_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	6 / 11	THR H 21 GLN H 22 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.37A	3mg0H-1q5rH: 23.8 3mg0I-1q5rH: 20.4	3mg0H-1q5rH: 27.16 3mg0I-1q5rH: 24.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_K_BO2K1402_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	8 / 11	ALA H 20 THR H 21 ALA H 27 VAL H 31 ALA H 46 GLY H 47 ALA H 49 SER H 141	None	0.53A	3mg0K-1q5rH: 23.9 3mg0L-1q5rH: 22.5	3mg0K-1q5rH: 27.59 3mg0L-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_V_BO2V1401_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	6 / 11	GLN H 22 ALA H 27 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.40A	3mg0V-1q5rH: 23.9 3mg0W-1q5rH: 23.3	3mg0V-1q5rH: 27.16 3mg0W-1q5rH: 24.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_V_BO2V1401_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 1 GLN H 22 ALA H 27 GLY H 47 THR H 48	None	1.03A	3mg0V-1q5rH: 23.9 3mg0W-1q5rH: 23.3	3mg0V-1q5rH: 27.16 3mg0W-1q5rH: 24.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_Y_BO2Y1403_1 (PROTEASOME COMPONENT PRE2 PROTEASOME COMPONENT C5)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	8 / 12	ALA H 20 THR H 21 ALA H 27 VAL H 31 ALA H 46 GLY H 47 ALA H 49 SER H 141	None	0.53A	3mg0Y-1q5rH: 13.4 3mg0Z-1q5rH: 22.2	3mg0Y-1q5rH: 27.59 3mg0Z-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RC0_A_SAMA484_0 (N-LYSINE METHYLTRANSFERASE SETD6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	VAL H 4 ALA H 15 GLY H 16 ALA H 214 LEU H 150	None	1.23A	3rc0A-1q5rH: undetectable	3rc0A-1q5rH: 22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ROD_D_NCAD302_0 (NICOTINAMIDE N-METHYLTRANSFERASE)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 7	LEU H 109 ASP H 108 ALA H 117 TYR H 107	None	1.08A	3rodD-1q5rH: undetectable	3rodD-1q5rH: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VAS_B_ADNB401_2 (PUTATIVE ADENOSINE KINASE)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 5	LEU H 63 ALA H 80 THR H 37 PHE H 76	None	1.35A	3vasB-1q5rH: undetectable	3vasB-1q5rH: 22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGZ_A_CQAA301_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 8	GLY H 127 LEU H 104 VAL H 121 TYR H 130	None	0.88A	4fgzA-1q5rH: undetectable	4fgzA-1q5rH: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAQ_A_2GMA2001_2 (CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 6	ILE H 3 THR H 1 VAL H 121 ASP H 124	None	0.86A	4iaqA-1q5rH: 0.5	4iaqA-1q5rH: 22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAR_A_ERMA2001_2 (CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 7	ILE H 3 THR H 1 VAL H 121 ASP H 124	None	0.90A	4iarA-1q5rH: undetectable	4iarA-1q5rH: 22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LUH_A_ACTA610_0 (SERUM ALBUMIN)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	3 / 3	VAL H 205 SER H 206 THR H 209	None	0.28A	4luhA-1q5rH: undetectable	4luhA-1q5rH: 17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.51A	4qvlK-1q5rH: 23.9 4qvlL-1q5rH: 22.5	4qvlK-1q5rH: 27.59 4qvlL-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVL_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.51A	4qvlY-1q5rH: 13.5 4qvlZ-1q5rH: 22.3	4qvlY-1q5rH: 27.59 4qvlZ-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.52A	4qvmK-1q5rH: 23.7 4qvmL-1q5rH: 22.3	4qvmK-1q5rH: 27.59 4qvmL-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.52A	4qvmY-1q5rH: 13.4 4qvmZ-1q5rH: 22.1	4qvmY-1q5rH: 27.59 4qvmZ-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.48A	4qvnK-1q5rH: 24.0 4qvnL-1q5rH: 22.5	4qvnK-1q5rH: 27.59 4qvnL-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.48A	4qvnY-1q5rH: 13.5 4qvnZ-1q5rH: 22.2	4qvnY-1q5rH: 27.59 4qvnZ-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.50A	4qvpK-1q5rH: 23.8 4qvpL-1q5rH: 22.2	4qvpK-1q5rH: 28.09 4qvpL-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.50A	4qvpY-1q5rH: 13.5 4qvpZ-1q5rH: 22.2	4qvpY-1q5rH: 28.09 4qvpZ-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.48A	4qvqK-1q5rH: 23.9 4qvqL-1q5rH: 22.4	4qvqK-1q5rH: 28.02 4qvqL-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.48A	4qvqY-1q5rH: 13.5 4qvqZ-1q5rH: 22.1	4qvqY-1q5rH: 28.02 4qvqZ-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.35A	4qvvH-1q5rH: 22.3	4qvvH-1q5rH: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 GLN H 22 ALA H 46 GLY H 47 ALA H 49	None	0.85A	4qvvH-1q5rH: 22.3	4qvvH-1q5rH: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.35A	4qvvV-1q5rH: 23.9	4qvvV-1q5rH: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 GLN H 22 ALA H 46 GLY H 47 ALA H 49	None	0.84A	4qvvV-1q5rH: 23.9	4qvvV-1q5rH: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.36A	4qvyH-1q5rH: 22.3	4qvyH-1q5rH: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 GLN H 22 ALA H 46 GLY H 47 ALA H 49	None	0.84A	4qvyH-1q5rH: 22.3	4qvyH-1q5rH: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 27 VAL H 31 GLY H 47	None	0.62A	4qvyK-1q5rH: 23.7 4qvyL-1q5rH: 22.4	4qvyK-1q5rH: 26.96 4qvyL-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 27 VAL H 31 GLY H 47	None	0.62A	4qvyY-1q5rH: 13.4 4qvyZ-1q5rH: 22.1	4qvyY-1q5rH: 26.96 4qvyZ-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	GLN H 22 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.79A	4qw1H-1q5rH: 22.3 4qw1I-1q5rH: 20.4	4qw1H-1q5rH: 26.88 4qw1I-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.48A	4qw1K-1q5rH: 23.9 4qw1L-1q5rH: 22.4	4qw1K-1q5rH: 27.59 4qw1L-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	GLN H 22 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.79A	4qw1V-1q5rH: 23.9 4qw1W-1q5rH: 23.3	4qw1V-1q5rH: 26.88 4qw1W-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.48A	4qw1Y-1q5rH: 17.7 4qw1Z-1q5rH: 22.2	4qw1Y-1q5rH: 27.59 4qw1Z-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.51A	4qw3K-1q5rH: 23.7 4qw3L-1q5rH: 22.2	4qw3K-1q5rH: 27.59 4qw3L-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.51A	4qw3Y-1q5rH: 17.5 4qw3Z-1q5rH: 21.9	4qw3Y-1q5rH: 27.59 4qw3Z-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	THR H 1 ALA H 20 THR H 21 ALA H 27 GLY H 47	None	1.13A	4qwuK-1q5rH: 23.3 4qwuL-1q5rH: 22.3	4qwuK-1q5rH: 27.59 4qwuL-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	THR H 1 ALA H 20 THR H 21 ALA H 27 GLY H 47	None	1.12A	4qwuY-1q5rH: 17.5 4qwuZ-1q5rH: 22.3	4qwuY-1q5rH: 27.59 4qwuZ-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R29_A_SAMA301_0 (UNCHARACTERIZED PROTEIN)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	ALA H 99 GLY H 92 ALA H 84 GLY H 127 TYR H 123	None	1.30A	4r29A-1q5rH: undetectable	4r29A-1q5rH: 21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R29_C_SAMC301_0 (UNCHARACTERIZED PROTEIN)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	ALA H 99 GLY H 92 ALA H 84 GLY H 127 TYR H 123	None	1.23A	4r29C-1q5rH: undetectable	4r29C-1q5rH: 21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z91_F_4LEF401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 7	THR H 196 LEU H 13 THR H 210 LEU H 213	None	0.87A	4z91F-1q5rH: undetectable 4z91G-1q5rH: undetectable 4z91H-1q5rH: undetectable 4z91I-1q5rH: undetectable 4z91J-1q5rH: undetectable	4z91F-1q5rH: 19.78 4z91G-1q5rH: 19.78 4z91H-1q5rH: 19.78 4z91I-1q5rH: 19.78 4z91J-1q5rH: 19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B8I_C_FK5C201_2 (CALCINEURIN SUBUNIT B, VARIANT PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 4	LEU H 83 MET H 86 VAL H 87 ASN H 90	None	1.34A	5b8iB-1q5rH: 0.3	5b8iB-1q5rH: 19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.49A	5bxnK-1q5rH: 23.9 5bxnL-1q5rH: 22.2	5bxnK-1q5rH: 27.59 5bxnL-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.31A	5bxnV-1q5rH: 24.0 5bxnW-1q5rH: 23.4	5bxnV-1q5rH: 26.61 5bxnW-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 GLN H 22 ALA H 46 GLY H 47 ALA H 49	None	0.80A	5bxnV-1q5rH: 24.0 5bxnW-1q5rH: 23.4	5bxnV-1q5rH: 26.61 5bxnW-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.49A	5bxnY-1q5rH: 13.5 5bxnZ-1q5rH: 22.2	5bxnY-1q5rH: 27.59 5bxnZ-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.51A	5d0xK-1q5rH: 23.8 5d0xL-1q5rH: 22.3	5d0xK-1q5rH: 23.23 5d0xL-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.34A	5d0xV-1q5rH: 23.9	5d0xV-1q5rH: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	THR H 21 GLN H 22 ALA H 46 GLY H 47 ALA H 49	None	0.76A	5d0xV-1q5rH: 23.9	5d0xV-1q5rH: 26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.51A	5d0xY-1q5rH: 13.5 5d0xZ-1q5rH: 22.1	5d0xY-1q5rH: 23.23 5d0xZ-1q5rH: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	GLN H 22 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.44A	5l5fH-1q5rH: 22.3 5l5fI-1q5rH: 20.3	5l5fH-1q5rH: 26.88 5l5fI-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	GLN H 22 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.46A	5l5fV-1q5rH: 23.9 5l5fW-1q5rH: 23.3	5l5fV-1q5rH: 26.88 5l5fW-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	THR H 21 GLN H 22 ALA H 46 GLY H 47 ALA H 49	None	0.39A	5l5zH-1q5rH: 22.3 5l5zI-1q5rH: 20.4	5l5zH-1q5rH: 26.88 5l5zI-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.64A	5l5zK-1q5rH: 23.7 5l5zL-1q5rH: 22.1	5l5zK-1q5rH: 28.38 5l5zL-1q5rH: 22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	THR H 21 GLN H 22 ALA H 46 GLY H 47 ALA H 49	None	0.40A	5l5zV-1q5rH: 23.8 5l5zW-1q5rH: 23.3	5l5zV-1q5rH: 26.88 5l5zW-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 9	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.64A	5l5zY-1q5rH: 23.7 5l5zZ-1q5rH: 22.1	5l5zY-1q5rH: 28.38 5l5zZ-1q5rH: 22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	GLN H 22 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.50A	5l66H-1q5rH: 22.3 5l66I-1q5rH: 20.4	5l66H-1q5rH: 26.88 5l66I-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 12	GLN H 22 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.50A	5l66V-1q5rH: 23.9 5l66W-1q5rH: 23.3	5l66V-1q5rH: 26.88 5l66W-1q5rH: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF3_H_BO2H306_1 (PROTEASOME SUBUNIT BETA TYPE-7 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 46 GLY H 47 ALA H 49	None	0.26A	5lf3H-1q5rH: 24.6 5lf3I-1q5rH: 23.0	5lf3H-1q5rH: 26.32 5lf3I-1q5rH: 22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF3_V_BO2V303_1 (PROTEASOME SUBUNIT BETA TYPE-7 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 10	ALA H 20 THR H 21 ALA H 46 GLY H 47 ALA H 49	None	0.30A	5lf3V-1q5rH: 24.5 5lf3W-1q5rH: 23.3	5lf3V-1q5rH: 26.32 5lf3W-1q5rH: 22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_H_6V8H305_0 (PROTEASOME SUBUNIT BETA TYPE-3 PROTEASOME SUBUNIT BETA TYPE-7)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 ALA H 46 GLY H 47 ALA H 49	None	0.32A	5lf7H-1q5rH: 24.6 5lf7I-1q5rH: 23.4	5lf7H-1q5rH: 26.32 5lf7I-1q5rH: 22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_K_6V8K305_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-5)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 VAL H 31 GLY H 47 ALA H 49	None	0.29A	5lf7K-1q5rH: 24.6 5lf7L-1q5rH: 23.2	5lf7K-1q5rH: 29.13 5lf7L-1q5rH: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_V_6V8V303_0 (PROTEASOME SUBUNIT BETA TYPE-3 PROTEASOME SUBUNIT BETA TYPE-7)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 ALA H 46 GLY H 47 ALA H 49	None	0.30A	5lf7V-1q5rH: 24.5 5lf7W-1q5rH: 23.4	5lf7V-1q5rH: 26.32 5lf7W-1q5rH: 22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_Y_6V8Y306_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-5)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 VAL H 31 GLY H 47 ALA H 49	None	0.30A	5lf7Y-1q5rH: 24.6 5lf7Z-1q5rH: 23.2	5lf7Y-1q5rH: 29.13 5lf7Z-1q5rH: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O96_C_SAMC501_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 7	LEU H 13 GLY H 11 GLY H 118 ALA H 163	None	0.66A	5o96C-1q5rH: undetectable	5o96C-1q5rH: 22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TE8_C_08JC602_1 (CYTOCHROME P450 3A4)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	4 / 7	SER H 170 LEU H 150 ALA H 138 ILE H 120	None	0.92A	5te8C-1q5rH: 0.8	5te8C-1q5rH: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_H_BO2H301_0 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	6 / 12	GLN H 22 ALA H 27 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.48A	6hwdH-1q5rH: 22.3 6hwdI-1q5rH: 20.4	6hwdH-1q5rH: 19.48 6hwdI-1q5rH: 12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_K_BO2K301_0 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.46A	6hwdK-1q5rH: 23.9 6hwdL-1q5rH: 22.5	6hwdK-1q5rH: 17.47 6hwdL-1q5rH: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_V_BO2V301_0 (PROTEASOME SUBUNIT BETA TYPE-2)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	6 / 11	GLN H 22 ALA H 27 ALA H 46 GLY H 47 THR H 48 ALA H 49	None	0.48A	6hwdV-1q5rH: 23.9	6hwdV-1q5rH: 19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_Y_BO2Y301_0 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1q5r	PROTEASOME BETA-TYPE SUBUNIT 1 (Rhodococcus erythropolis)	5 / 11	ALA H 20 THR H 21 ALA H 27 GLY H 47 ALA H 49	None	0.46A	6hwdY-1q5rH: 17.6 6hwdZ-1q5rH: 22.3	6hwdY-1q5rH: 17.47 6hwdZ-1q5rH: 14.81

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1MX1_B_THAB2_1","LIVER CARBOXYLESTERASE I","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"LEU H  14;GLY H  44;VAL H  87;LEU H 104;LEU H  83","None","1.24A","1mx1B-1q5rH:undetectable","1mx1B-1q5rH:20.73"],["1MX1_C_THAC3_1","LIVER CARBOXYLESTERASE I","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"LEU H  14;GLY H  44;VAL H  87;LEU H 104;LEU H  83","None","1.21A","1mx1C-1q5rH:undetectable","1mx1C-1q5rH:20.73"],["1MX1_E_THAE5_1","LIVER CARBOXYLESTERASE I","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"LEU H  14;GLY H  44;VAL H  87;LEU H 104;LEU H  83","None","1.19A","1mx1E-1q5rH:undetectable","1mx1E-1q5rH:20.73"],["2F16_H_BO2H1400_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",6,"GLN H  22;ALA H  27;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.49A","2f16H-1q5rH:23.8;2f16I-1q5rH:20.5","2f16H-1q5rH:27.16;2f16I-1q5rH:24.64"],["2F16_K_BO2K1402_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",6,"ALA H  20;THR H  21;ALA H  27;VAL H  31;GLY H  47;ALA H  49","None","0.47A","2f16K-1q5rH:23.8;2f16L-1q5rH:22.5","2f16K-1q5rH:27.59;2f16L-1q5rH:22.70"],["2F16_V_BO2V1401_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",6,"GLN H  22;ALA H  27;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.50A","2f16V-1q5rH:23.8;2f16W-1q5rH:23.4","2f16V-1q5rH:27.16;2f16W-1q5rH:24.64"],["2F16_Y_BO2Y1403_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",6,"ALA H  20;THR H  21;ALA H  27;VAL H  31;GLY H  47;ALA H  49","None","0.47A","2f16Y-1q5rH:13.4;2f16Z-1q5rH:22.3","2f16Y-1q5rH:27.59;2f16Z-1q5rH:22.70"],["2VCV_G_ASDG1224_1","GLUTATHIONE S-TRANSFERASE A3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"LEU H  14;ALA H 167;LEU H 171;ALA H 146","None","0.90A","2vcvG-1q5rH:undetectable","2vcvG-1q5rH:25.76"],["3KEE_B_30BB500_1","GENOME POLYPROTEIN","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"GLY H  -1;VAL H 195;GLY H  16;ALA H  43;ALA H  42","None","1.11A","3keeB-1q5rH:undetectable","3keeB-1q5rH:22.85"],["3KEE_C_30BC500_1","GENOME POLYPROTEIN","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"GLY H  -1;VAL H 195;GLY H  16;ALA H  43;ALA H  42","None","1.06A","3keeC-1q5rH:undetectable","3keeC-1q5rH:22.85"],["3MG0_H_BO2H1400_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H   1;THR H  21;GLN H  22;GLY H  47;THR H  48","None","1.03A","3mg0H-1q5rH:23.8;3mg0I-1q5rH:20.4","3mg0H-1q5rH:27.16;3mg0I-1q5rH:24.64"],["3MG0_H_BO2H1400_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",6,"THR H  21;GLN H  22;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.37A","3mg0H-1q5rH:23.8;3mg0I-1q5rH:20.4","3mg0H-1q5rH:27.16;3mg0I-1q5rH:24.64"],["3MG0_K_BO2K1402_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",8,"ALA H  20;THR H  21;ALA H  27;VAL H  31;ALA H  46;GLY H  47;ALA H  49;SER H 141","None","0.53A","3mg0K-1q5rH:23.9;3mg0L-1q5rH:22.5","3mg0K-1q5rH:27.59;3mg0L-1q5rH:22.70"],["3MG0_V_BO2V1401_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",6,"GLN H  22;ALA H  27;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.40A","3mg0V-1q5rH:23.9;3mg0W-1q5rH:23.3","3mg0V-1q5rH:27.16;3mg0W-1q5rH:24.64"],["3MG0_V_BO2V1401_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H   1;GLN H  22;ALA H  27;GLY H  47;THR H  48","None","1.03A","3mg0V-1q5rH:23.9;3mg0W-1q5rH:23.3","3mg0V-1q5rH:27.16;3mg0W-1q5rH:24.64"],["3MG0_Y_BO2Y1403_1","PROTEASOME COMPONENT PRE2;PROTEASOME COMPONENT C5","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",8,"ALA H  20;THR H  21;ALA H  27;VAL H  31;ALA H  46;GLY H  47;ALA H  49;SER H 141","None","0.53A","3mg0Y-1q5rH:13.4;3mg0Z-1q5rH:22.2","3mg0Y-1q5rH:27.59;3mg0Z-1q5rH:22.70"],["3RC0_A_SAMA484_0","N-LYSINE METHYLTRANSFERASE SETD6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"VAL H   4;ALA H  15;GLY H  16;ALA H 214;LEU H 150","None","1.23A","3rc0A-1q5rH:undetectable","3rc0A-1q5rH:22.42"],["3ROD_D_NCAD302_0","NICOTINAMIDE N-METHYLTRANSFERASE","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"LEU H 109;ASP H 108;ALA H 117;TYR H 107","None","1.08A","3rodD-1q5rH:undetectable","3rodD-1q5rH:22.84"],["3VAS_B_ADNB401_2","PUTATIVE ADENOSINE KINASE","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"LEU H  63;ALA H  80;THR H  37;PHE H  76","None","1.35A","3vasB-1q5rH:undetectable","3vasB-1q5rH:22.66"],["4FGZ_A_CQAA301_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"GLY H 127;LEU H 104;VAL H 121;TYR H 130","None","0.88A","4fgzA-1q5rH:undetectable","4fgzA-1q5rH:21.54"],["4IAQ_A_2GMA2001_2","CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"ILE H   3;THR H   1;VAL H 121;ASP H 124","None","0.86A","4iaqA-1q5rH:0.5","4iaqA-1q5rH:22.46"],["4IAR_A_ERMA2001_2","CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 1B AND E. COLI SOLUBLE CYTOCHROME B562","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"ILE H   3;THR H   1;VAL H 121;ASP H 124","None","0.90A","4iarA-1q5rH:undetectable","4iarA-1q5rH:22.57"],["4LUH_A_ACTA610_0","SERUM ALBUMIN","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",3,"VAL H 205;SER H 206;THR H 209","None","0.28A","4luhA-1q5rH:undetectable","4luhA-1q5rH:17.84"],["4QVL_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.51A","4qvlK-1q5rH:23.9;4qvlL-1q5rH:22.5","4qvlK-1q5rH:27.59;4qvlL-1q5rH:22.70"],["4QVL_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.51A","4qvlY-1q5rH:13.5;4qvlZ-1q5rH:22.3","4qvlY-1q5rH:27.59;4qvlZ-1q5rH:22.70"],["4QVM_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.52A","4qvmK-1q5rH:23.7;4qvmL-1q5rH:22.3","4qvmK-1q5rH:27.59;4qvmL-1q5rH:22.70"],["4QVM_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.52A","4qvmY-1q5rH:13.4;4qvmZ-1q5rH:22.1","4qvmY-1q5rH:27.59;4qvmZ-1q5rH:22.70"],["4QVN_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.48A","4qvnK-1q5rH:24.0;4qvnL-1q5rH:22.5","4qvnK-1q5rH:27.59;4qvnL-1q5rH:22.70"],["4QVN_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.48A","4qvnY-1q5rH:13.5;4qvnZ-1q5rH:22.2","4qvnY-1q5rH:27.59;4qvnZ-1q5rH:22.70"],["4QVP_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.50A","4qvpK-1q5rH:23.8;4qvpL-1q5rH:22.2","4qvpK-1q5rH:28.09;4qvpL-1q5rH:22.70"],["4QVP_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.50A","4qvpY-1q5rH:13.5;4qvpZ-1q5rH:22.2","4qvpY-1q5rH:28.09;4qvpZ-1q5rH:22.70"],["4QVQ_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.48A","4qvqK-1q5rH:23.9;4qvqL-1q5rH:22.4","4qvqK-1q5rH:28.02;4qvqL-1q5rH:22.70"],["4QVQ_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.48A","4qvqY-1q5rH:13.5;4qvqZ-1q5rH:22.1","4qvqY-1q5rH:28.02;4qvqZ-1q5rH:22.70"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.35A","4qvvH-1q5rH:22.3","4qvvH-1q5rH:26.88"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;GLN H  22;ALA H  46;GLY H  47;ALA H  49","None","0.85A","4qvvH-1q5rH:22.3","4qvvH-1q5rH:26.88"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.35A","4qvvV-1q5rH:23.9","4qvvV-1q5rH:26.88"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;GLN H  22;ALA H  46;GLY H  47;ALA H  49","None","0.84A","4qvvV-1q5rH:23.9","4qvvV-1q5rH:26.88"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.36A","4qvyH-1q5rH:22.3","4qvyH-1q5rH:26.88"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;GLN H  22;ALA H  46;GLY H  47;ALA H  49","None","0.84A","4qvyH-1q5rH:22.3","4qvyH-1q5rH:26.88"],["4QVY_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;VAL H  31;GLY H  47","None","0.62A","4qvyK-1q5rH:23.7;4qvyL-1q5rH:22.4","4qvyK-1q5rH:26.96;4qvyL-1q5rH:22.70"],["4QVY_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;VAL H  31;GLY H  47","None","0.62A","4qvyY-1q5rH:13.4;4qvyZ-1q5rH:22.1","4qvyY-1q5rH:26.96;4qvyZ-1q5rH:22.70"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"GLN H  22;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.79A","4qw1H-1q5rH:22.3;4qw1I-1q5rH:20.4","4qw1H-1q5rH:26.88;4qw1I-1q5rH:23.33"],["4QW1_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.48A","4qw1K-1q5rH:23.9;4qw1L-1q5rH:22.4","4qw1K-1q5rH:27.59;4qw1L-1q5rH:22.70"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"GLN H  22;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.79A","4qw1V-1q5rH:23.9;4qw1W-1q5rH:23.3","4qw1V-1q5rH:26.88;4qw1W-1q5rH:23.33"],["4QW1_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.48A","4qw1Y-1q5rH:17.7;4qw1Z-1q5rH:22.2","4qw1Y-1q5rH:27.59;4qw1Z-1q5rH:22.70"],["4QW3_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.51A","4qw3K-1q5rH:23.7;4qw3L-1q5rH:22.2","4qw3K-1q5rH:27.59;4qw3L-1q5rH:22.70"],["4QW3_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.51A","4qw3Y-1q5rH:17.5;4qw3Z-1q5rH:21.9","4qw3Y-1q5rH:27.59;4qw3Z-1q5rH:22.70"],["4QWU_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H   1;ALA H  20;THR H  21;ALA H  27;GLY H  47","None","1.13A","4qwuK-1q5rH:23.3;4qwuL-1q5rH:22.3","4qwuK-1q5rH:27.59;4qwuL-1q5rH:22.70"],["4QWU_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H   1;ALA H  20;THR H  21;ALA H  27;GLY H  47","None","1.12A","4qwuY-1q5rH:17.5;4qwuZ-1q5rH:22.3","4qwuY-1q5rH:27.59;4qwuZ-1q5rH:22.70"],["4R29_A_SAMA301_0","UNCHARACTERIZED PROTEIN","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  99;GLY H  92;ALA H  84;GLY H 127;TYR H 123","None","1.30A","4r29A-1q5rH:undetectable","4r29A-1q5rH:21.33"],["4R29_C_SAMC301_0","UNCHARACTERIZED PROTEIN","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  99;GLY H  92;ALA H  84;GLY H 127;TYR H 123","None","1.23A","4r29C-1q5rH:undetectable","4r29C-1q5rH:21.33"],["4Z91_F_4LEF401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"THR H 196;LEU H  13;THR H 210;LEU H 213","None","0.87A","4z91F-1q5rH:undetectable;4z91G-1q5rH:undetectable;4z91H-1q5rH:undetectable;4z91I-1q5rH:undetectable;4z91J-1q5rH:undetectable","4z91F-1q5rH:19.78;4z91G-1q5rH:19.78;4z91H-1q5rH:19.78;4z91I-1q5rH:19.78;4z91J-1q5rH:19.78"],["5B8I_C_FK5C201_2","CALCINEURIN SUBUNIT B, VARIANT;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"LEU H  83;MET H  86;VAL H  87;ASN H  90","None","1.34A","5b8iB-1q5rH:0.3","5b8iB-1q5rH:19.53"],["5BXN_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.49A","5bxnK-1q5rH:23.9;5bxnL-1q5rH:22.2","5bxnK-1q5rH:27.59;5bxnL-1q5rH:22.70"],["5BXN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.31A","5bxnV-1q5rH:24.0;5bxnW-1q5rH:23.4","5bxnV-1q5rH:26.61;5bxnW-1q5rH:23.33"],["5BXN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;GLN H  22;ALA H  46;GLY H  47;ALA H  49","None","0.80A","5bxnV-1q5rH:24.0;5bxnW-1q5rH:23.4","5bxnV-1q5rH:26.61;5bxnW-1q5rH:23.33"],["5BXN_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.49A","5bxnY-1q5rH:13.5;5bxnZ-1q5rH:22.2","5bxnY-1q5rH:27.59;5bxnZ-1q5rH:22.70"],["5D0X_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.51A","5d0xK-1q5rH:23.8;5d0xL-1q5rH:22.3","5d0xK-1q5rH:23.23;5d0xL-1q5rH:22.70"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.34A","5d0xV-1q5rH:23.9","5d0xV-1q5rH:26.88"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;GLN H  22;ALA H  46;GLY H  47;ALA H  49","None","0.76A","5d0xV-1q5rH:23.9","5d0xV-1q5rH:26.88"],["5D0X_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.51A","5d0xY-1q5rH:13.5;5d0xZ-1q5rH:22.1","5d0xY-1q5rH:23.23;5d0xZ-1q5rH:22.70"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"GLN H  22;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.44A","5l5fH-1q5rH:22.3;5l5fI-1q5rH:20.3","5l5fH-1q5rH:26.88;5l5fI-1q5rH:23.33"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"GLN H  22;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.46A","5l5fV-1q5rH:23.9;5l5fW-1q5rH:23.3","5l5fV-1q5rH:26.88;5l5fW-1q5rH:23.33"],["5L5Z_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;GLN H  22;ALA H  46;GLY H  47;ALA H  49","None","0.39A","5l5zH-1q5rH:22.3;5l5zI-1q5rH:20.4","5l5zH-1q5rH:26.88;5l5zI-1q5rH:23.33"],["5L5Z_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.64A","5l5zK-1q5rH:23.7;5l5zL-1q5rH:22.1","5l5zK-1q5rH:28.38;5l5zL-1q5rH:22.37"],["5L5Z_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"THR H  21;GLN H  22;ALA H  46;GLY H  47;ALA H  49","None","0.40A","5l5zV-1q5rH:23.8;5l5zW-1q5rH:23.3","5l5zV-1q5rH:26.88;5l5zW-1q5rH:23.33"],["5L5Z_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.64A","5l5zY-1q5rH:23.7;5l5zZ-1q5rH:22.1","5l5zY-1q5rH:28.38;5l5zZ-1q5rH:22.37"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"GLN H  22;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.50A","5l66H-1q5rH:22.3;5l66I-1q5rH:20.4","5l66H-1q5rH:26.88;5l66I-1q5rH:23.33"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"GLN H  22;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.50A","5l66V-1q5rH:23.9;5l66W-1q5rH:23.3","5l66V-1q5rH:26.88;5l66W-1q5rH:23.33"],["5LF3_H_BO2H306_1","PROTEASOME SUBUNIT BETA TYPE-7;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  46;GLY H  47;ALA H  49","None","0.26A","5lf3H-1q5rH:24.6;5lf3I-1q5rH:23.0","5lf3H-1q5rH:26.32;5lf3I-1q5rH:22.26"],["5LF3_V_BO2V303_1","PROTEASOME SUBUNIT BETA TYPE-7;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  46;GLY H  47;ALA H  49","None","0.30A","5lf3V-1q5rH:24.5;5lf3W-1q5rH:23.3","5lf3V-1q5rH:26.32;5lf3W-1q5rH:22.26"],["5LF7_H_6V8H305_0","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  46;GLY H  47;ALA H  49","None","0.32A","5lf7H-1q5rH:24.6;5lf7I-1q5rH:23.4","5lf7H-1q5rH:26.32;5lf7I-1q5rH:22.26"],["5LF7_K_6V8K305_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-5","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;VAL H  31;GLY H  47;ALA H  49","None","0.29A","5lf7K-1q5rH:24.6;5lf7L-1q5rH:23.2","5lf7K-1q5rH:29.13;5lf7L-1q5rH:22.90"],["5LF7_V_6V8V303_0","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  46;GLY H  47;ALA H  49","None","0.30A","5lf7V-1q5rH:24.5;5lf7W-1q5rH:23.4","5lf7V-1q5rH:26.32;5lf7W-1q5rH:22.26"],["5LF7_Y_6V8Y306_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-5","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;VAL H  31;GLY H  47;ALA H  49","None","0.30A","5lf7Y-1q5rH:24.6;5lf7Z-1q5rH:23.2","5lf7Y-1q5rH:29.13;5lf7Z-1q5rH:22.90"],["5O96_C_SAMC501_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"LEU H  13;GLY H  11;GLY H 118;ALA H 163","None","0.66A","5o96C-1q5rH:undetectable","5o96C-1q5rH:22.58"],["5TE8_C_08JC602_1","CYTOCHROME P450 3A4","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",4,"SER H 170;LEU H 150;ALA H 138;ILE H 120","None","0.92A","5te8C-1q5rH:0.8","5te8C-1q5rH:19.76"],["6HWD_H_BO2H301_0","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",6,"GLN H  22;ALA H  27;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.48A","6hwdH-1q5rH:22.3;6hwdI-1q5rH:20.4","6hwdH-1q5rH:19.48;6hwdI-1q5rH:12.93"],["6HWD_K_BO2K301_0","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.46A","6hwdK-1q5rH:23.9;6hwdL-1q5rH:22.5","6hwdK-1q5rH:17.47;6hwdL-1q5rH:14.81"],["6HWD_V_BO2V301_0","PROTEASOME SUBUNIT BETA TYPE-2","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",6,"GLN H  22;ALA H  27;ALA H  46;GLY H  47;THR H  48;ALA H  49","None","0.48A","6hwdV-1q5rH:23.9","6hwdV-1q5rH:19.48"],["6HWD_Y_BO2Y301_0","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1q5r","PROTEASOME BETA-TYPE SUBUNIT 1","Rhodococcus erythropolis",5,"ALA H  20;THR H  21;ALA H  27;GLY H  47;ALA H  49","None","0.46A","6hwdY-1q5rH:17.6;6hwdZ-1q5rH:22.3","6hwdY-1q5rH:17.47;6hwdZ-1q5rH:14.81"]]